NPM1 and acute myeloid leukemia: Important issues to be evaluated during the diagnose and treatment of NPM1-mutated AML are the NPM1 mutational status, the timing of HSCT, MRD monitoring and ELN (Elastin) genetic-based risk stratification [124].